2021/2552(RSP) Resolution on Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
Lead committee dossier:
Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | ARENA Maria ( S&D), METZ Tilly ( Verts/ALE), HAZEKAMP Anja ( Confederal Group of the European United Left) |
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
2021/03/11
EP - Text adopted by Parliament, single reading
Documents
2021/03/11
EP - Decision by Parliament, 1st reading/single reading
Documents
2021/03/11
EP - End of procedure in Parliament
2021/03/09
EP - Motion for a resolution
Documents
2021/02/09
EP - ARENA Maria (S&D) appointed as rapporteur in ENVI
2021/02/09
EP - METZ Tilly (Verts/ALE) appointed as rapporteur in ENVI
2021/02/09
EP - HAZEKAMP Anja (Confederal Group of the European United Left) appointed as rapporteur in ENVI
Documents
- Text adopted by Parliament, single reading: T9-0079/2021
- Decision by Parliament, 1st reading/single reading: T9-0079/2021
- Motion for a resolution: B9-0162/2021
- Motion for a resolution: B9-0162/2021
- Text adopted by Parliament, single reading: T9-0079/2021
Activities
- Maria ARENA
Institutional Motions (1)
- Anja HAZEKAMP
Institutional Motions (1)
- Tilly METZ
Institutional Motions (1)
Votes
Objection formulée conformément à l'article 112, paragraphes 2 et 3: substances actives, notamment la dimoxystrobine - Objection pursuant to Rule 112(2) and (3): Active substances, including dimoxystrobin - Einwand gemäß Artikel 112 Absätze 2 und 3 (GO): Wirkstoffe wie Dimoxystrobin - B9-0162/2021 - Proposition de résolution #
2021/03/10 Outcome: +: 472, -: 214, 0: 9
History
(these mark the time of scraping, not the official date of the change)
2021-12-18Show (7) Changes | Timetravel
committees/0 |
|
committees/0 |
|
docs/1 |
|
docs/1 |
|
events/0 |
|
events/0 |
|
events/1 |
|
2021-03-17Show (3) Changes | Timetravel
docs/1 |
|
events |
|
procedure/stage_reached |
Old
Awaiting plenary debate/voteNew
Procedure completed |
2021-03-16Show (3) Changes
docs |
|
forecasts |
|
procedure/title |
Old
Objection pursuant to Rule 112(2) and (3) on the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobinNew
Resolution on Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin |